Scheiner, Matthias
University of Würzburg
3 papers on CoChatORCID 0000-0003-0596-4725
Most cited papers
- Verified
Highly Selective Butyrylcholinesterase Inhibitors With Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer’s Disease Mouse Model
Hoffmann, M., Stiller, C., Endres, E., Scheiner, M., Gunesch, S., Sotriffer, C., Maurice, T., & Decker, M. (2019) · Journal of Medicinal Chemistry
Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments
Cited by 105
- Verified
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., et al. (2021) · Journal of Medicinal Chemistry
Histone Deacetylase Inhibitors ResearchCholinesterase and Neurodegenerative Diseases
Cited by 66
- Verified
Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry
Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments
Cited by 49
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free